Merck, P302-05, Porcine Pulmonary Artery Endothelial Cells: PPAEC (Cryovial)

General description
Lot specific orders are not able to be placed through the web. Contact your local sales rep for more details.

PPAEC have been used in a pioneer study of endothelial cell motility, where it was determined that asymmetric dimethylarginine (ADMA), an inhibitor of nitric oxide production and a cardiovascular risk factor, decreased PKG-mediated phosphorylation of VASP, leading to downregulation of Rac1 and induction of stress fibers and focal adhesions via RhoA/ROCK dependent mechanism, leading to decreased cell motility, and increase in endothelial permeability, thus linking vascular repair and function with NO production (Wojciak-Stothard, 2007, 2009). PPAEC were also used to assess endothelial adhesion to decellularized porcine arteries in order to develop grafts for human vascular repair (Xiong, 2013).
Application
cardiovascular function, screening of drug candidates, angiogenesis, vasodilator function, transport of deoxygenated bloood from heart to lungs
Biochem/physiol Actions
Artery
Preparation Note

• 1st passage, >500,000 cells in Porcine Endothelial Cell Growth Medium that contains 10% FBS and 10% DMSO
• Can be cultured at least 16 doublings

Please refer to the PPAEC Culture Protocol.
Other Notes
Porcine Endothelial Cell Growth Medium that contains 10% FBS and 10% DMSO